Meconium Is A Potent Activator of Complement in Human Serum and in Piglets

Pediatric Research

Volumn 55, Issue 2, 2004, Pages 310-318

  Castellheim, Albert ^a   Lindenskov, Paal H H ^a   Pharo, Anne ^a   Fung, Michael ^b   Saugstad, Ola D ^a   Mollnes, Tom E ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b Tanox Biosystems Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BILE ACID; COMPLEMENT COMPONENT C1R; COMPLEMENT COMPONENT C2; COMPLEMENT COMPONENT C3B; COMPLEMENT COMPONENT C4B; COMPLEMENT COMPONENT C5; COMPLEMENT FACTOR D; FATTY ACID; LECTIN; MANNOSE BINDING LECTIN;

ARTICLE; ARTIFICIAL VENTILATION; COMPLEMENT ACTIVATION; COMPLEMENT ALTERNATIVE PATHWAY; COMPLEMENT INHIBITION; COMPLEMENT SYSTEM; CONTROLLED STUDY; HUMAN; INFLAMMATION; LUNG COMPLICATION; LUNG INSUFFICIENCY; MECONIUM; MECONIUM ASPIRATION; MORBIDITY; MORTALITY; NEWBORN; NONHUMAN; PALLIATIVE THERAPY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SERUM; SWINE;

AGE FACTORS; ANIMALS; ANTICOAGULANTS; COMPLEMENT ACTIVATION; COMPLEMENT C1; DEXTRAN SULFATE; FEMALE; FETAL BLOOD; HUMANS; INFANT, NEWBORN; LIPOPOLYSACCHARIDES; MECONIUM; MECONIUM ASPIRATION SYNDROME; PREGNANCY; SERUM; SERUM ALBUMIN; SWINE;

EID: 1642433274     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/01.PDR.0000100902.76021.8E     Document Type: Article

References (51)

1. Fuloria M, Wiswell TE 1999 Resuscitation of the meconium-stained infant and prevention of meconium aspiration syndrome. J Perinatol 19:234-241
2. Cleary GM, Wiswell TE 1998 Meconium-stained amniotic fluid and the meconium aspiration syndrome. An update. Pediatr Clin North Am 45:511-529
3. Wiswell TE, Fuloria M 1998 The meconium aspiration syndrome: the saga continues. Indian Pediatr 35:1059-1062
4. Ghidini A, Spong CY 2001 Severe meconium aspiration syndrome is not caused by aspiration of meconium. Am J Obstet Gynecol 185:931-938
5. Soukka H, Rautanen M, Halkola L, Kero P, Kaapa P 1997 Meconium aspiration induces ARDS-like pulmonary response in lungs of ten-week-old pigs. Pediatr Pulmonol 23:205-211
6. Fry DE 2000 Sepsis syndrome. Am Surg 66:126-132
7. Cheng IW, Ware LB, Greene KE, Nuckton TJ, Eisner MD, Matthay MA 2003 Prognostic value of surfactant proteins A and D in patients with acute lung injury. Crit Care Med 31:20-27
8. Slutsky AS, Tremblay LN 1998 Multiple system organ failure. Is mechanical ventilation a contributing factor? Am J Respir Crit Care Med 157:1721-1725
9. Kearney MS 1999 Chronic intrauterine meconium aspiration causes fetal lung infarcts, lung rupture, and meconium embolism. Pediatr Dev Pathol 2:544-551
10. Katz VL, Bowes WA Jr 1992 Meconium aspiration syndrome: reflections on a murky subject. Am J Obstet Gynecol 166:171-183
11. Srinivasan HB, Vidyasagar D 1999 Meconium aspiration syndrome: current concepts and management. Compr Ther 25:82-89
12. Klingner MC, Kruse J 1999 Meconium aspiration syndrome: pathophysiology and prevention. J Am Board Fam Pract 12:450-466
13. Yeh TF, Srinivasan G, Harris V, Pildes RS 1977 Hydrocortisone therapy in meconium aspiration syndrome: a controlled study. J Pediatr 90:140-143
14. McCabe AJ, Wilcox DT, Holm BA, Glick PL 2000 Surfactant - a review for pediatric surgeons. J Pediatr Surg 35:1687-1700
15. Kattwinkel J 2002 Surfactant lavage for meconium aspiration: a word of caution. Pediatrics 109:1167-1168
16. Vidyasagar D, Harris V, Pildes RS 1975 Assisted ventilation in infants with meconium aspiration syndrome. Pediatrics 56:208-213
17. Gill BS, Neville HL, Khan AM, Cox CS Jr, Lally KP 2002 Delayed institution of extracorporeal membrane oxygenation is associated with increased mortality rate and prolonged hospital stay. J Pediatr Surg 37:7-10
18. Fung M, Loubser PG, Undar A, Mueller M, Sun C, Sun WN, Vaughn WK, Fraser CD Jr 2001 Inhibition of complement, neutrophil, and platelet activation by an anti-factor D monoclonal antibody in simulated cardiopulmonary bypass circuits. J Thorac Cardiovasc Surg 122:113-122
19. Fure H, Nielsen EW, Hack CE, Mollnes TE 1997 A neoepitope-based enzyme immunoassay for quantification of C1-inhibitor in complex with Clr and Cls. Scand J Immunol 46:553-557
20. Wolbink GJ, Bollen J, Baars JW, ten Berge RJ, Swaak AJ, Paardekooper J, Hack CE 1993 Application of a monoclonal antibody against a neoepitope on activated C4 in an ELISA for the quantification of complement activation via the classical pathway. J Immunol Methods 163:67-76
21. Mollnes TE, Brekke OL, Fung M, Fure H, Christiansen D, Bergseth G, Videm V, Lappegard KT, Kohl J, Lambris JD 2002 Essential role of the C5a receptor in E coli-induced oxidative burst and phagocytosis revealed by a novel lepirudin-based human whole blood model of inflammation. Blood 100:1869-1877
22. Garred P, Mollnes TE, Lea T 1988 Quantification in enzyme-linked immunosorbent assay of a C3 neoepitope expressed on activated human complement factor C3. Scand J Immunol 27:329-335
23. Mollnes TE, Lea T, Frøland SS, Harboe M 1985 Quantification of the terminal complement complex in human plasma by an enzyme-linked immunosorbent assay based on monoclonal antibodies against a neoantigen of the complex. Scand J Immunol 22:197-202
24. Mollnes TE, Lea T, Harboe M, Tschopp J 1985 Monoclonal antibodies recognizing a neoantigen of poly(C9) detect the human terminal complement complex in tissue and plasma. Scand J Immunol 22:183-195
25. Tølløfsrud PA, Solås AB, Saugstad OD 2001 Newborn piglets with meconium aspiration resuscitated with room air or 100% oxygen. Pediatr Res 50:423-429
26. Tølløfsrud PA, Medbø S, Solås AB, Drevon CA, Saugstad OD 2002 Albumin mixed with meconium attenuates pulmonary dysfunction in a newborn piglet model with meconium aspiration. Pediatr Res 52:545-553
27. Oberholzer A, Oberholzer C, Moldawer LL 2000 Cytokine signaling-regulation of the immune response in normal and critically ill states. Crit Care Med 28:N3-N12
28. Baggiolini M, Loetscher P 2000 Chemokines in inflammation and immunity. Immunol Today 21:418-420
29. Bulger EM, Maier RV 2000 Lipid mediators in the pathophysiology of critical illness. Crit Care Med 28:N27-N36
30. Khan AM, Elidemir O, Epstein CE, Lally KP, Xue H, Blackburn M, Larsen GL, Colasurdo GN 2002 Meconium aspiration produces airway hyperresponsiveness and eosinophilic inflammation in a murine model. Am J Physiol 283:L785-L790
31. Korhonen K, Soukka H, Halkola L, Peuravuori H, Aho H, Pulkki K, Kero P, Kaapa PO 2003 Meconium induces only localized inflammatory lung injury in piglets. Pediatr Res 54:192-197
32. Mollnes TE, Song WC, Lambris JD 2002 Complement in inflammatory tissue damage and disease. Trends Immunol 23:61-64
33. Bhole D, Stahl GL 2003 Therapeutic potential of targeting the complement cascade in critical care medicine. Crit Care Med 31:S97-S104
34. Atkinson JP, Oglesby TJ, White D, Adams EA, Liszewski MK 1991 Separation of self from non-self in the complement system: a role for membrane cofactor protein and decay accelerating factor. Clin Exp Immunol 86 Suppl 1:27-30
35. Ward PA 1994 Oxygen radicals, cytokines, adhesion molecules, and lung injury. Environ Health Perspect 102(suppl 10):13-16
36. Nishizawa H, Yamada H, Miyazaki H, Ohara M, Kaneko K, Yamakawa T, Wiener-Kronish J, Kudoh I 1996 Soluble complement receptor type 1 inhibited the systemic organ injury caused by acid instillation into a lung. Anesthesiology 85:1120-1128
37. Kyriakides C, Austen W Jr, Wang Y, Favuzza J, Kobzik L, Moore FD Jr, Hechtman HB 1999 Membrane attack complex of complement and neutrophils mediate the injury of acid aspiration. J Appl Physiol 87:2357-2361
38. Kyriakides C, Wang Y, Austen WG Jr, Favuzza J, Kobzik L, Moore FD Jr, Hechtman HB 2001 Sialyl Lewis(x) hybridized complement receptor type 1 moderates acid aspiration injury. Am J Physiol 281:L1494-L1499
39. Kyriakides C, Austen WG Jr, Wang Y, Favuzza J, Kobzik L, Moore FD Jr, Hechtman HB 2001 Mast cells mediate complement activation after acid aspiration. Shock 16:21-24
40. Petersen SV, Thiel S, Jensen L, Vorup-Jensen T, Koch C, Jensenius JC 2000 Control of the classical and the MBL pathway of complement activation. Mol Immunol 37:803-811
41. Caliezi C, Wuillemin WA, Zeerleder S, Redondo M, Eisele B, Hack CE 2000 C1-Esterase inhibitor: an anti-inflammatory agent and its potential use in the treatment of diseases other than hereditary angioedema. Pharmacol Rev 52:91-112
42. Jiang H, Wagner E, Zhang H, Frank MM 2001 Complement 1 inhibitor is a regulator of the alternative complement pathway. J Exp Med 194:1609-1616
43. Edens RE, Linhardt RJ, Weiler JM 1993 Heparin is not just an anticoagulant anymore: six and one-half decades of studies on the ability of heparin to regulate complement activity. In: Cruse JM, Lewis RE (eds) Complement Today. Karger, Basel, pp 96-120
44. Wuillemin WA, te Velthuis H, Lubbers YT, de Ruig CP, Eldering E, Hack CE 1997 Potentiation of C1 inhibitor by glycosaminoglycans: dextran sulfate species are effective inhibitors of in vitro complement activation in plasma. J Immunol 159:1953-1960
45. Fiorante P, Banz Y, Mohacsi PJ, Kappeler A, Wuillemin WA, Macchiarini P, Roos A, Daha MR, Schaffner T, Haeberli A, Mazmanian GM, Rieben R 2001 Low molecular weight dextran sulfate prevents complement activation and delays hyperacute rejection in pig-to-human xenotransplantation models. Xenotransplantation 8:24-35
46. Koistinen V 1993 Effects of sulphated polyanions on functions of complement factor H. Mol Immunol 30:113-118
47. Bos IG, van Mierlo GJ, Bleeker WK, Rigter GM, te Velthuis H, Dickneite G, Hack CE 2001 The potentiation of human C1-inhibitor by dextran sulphate is transient in vivo: studies in a rat model. Int Immunopharmacol 1:1583-1595
48. Wu JM, Yeh TF, Wang JY, Wang JN, Lin YJ, Hsieh WS, Lin CH 1999 The role of pulmonary inflammation in the development of pulmonary hypertension in newborn with meconium aspiration syndrome (MAS). Pediatr Pulmonol Suppl 18:205-208
49. Oberholzer A, Oberholzer C, Moldawer LL 2001 Sepsis syndromes: understanding the role of innate and acquired immunity. Shock 16:83-96
50. Horstick G, Berg O, Heimann A, Gotze O, Loos M, Hafner G, Bierbach B, Petersen S, Bhakdi S, Darius H, Horstick M, Meyer J, Kempski O 2001 Application of C1-esterase inhibitor during reperfusion of ischemic myocardium: dose-related beneficial versus detrimental effects. Circulation 104:3125-3131
51. Zeerleder S, Mauron T, Lammle B, Wuillemin WA 2002 Effect of low-molecular weight dextran sulfate on coagulation and platelet function tests. Thromb Res 105:441-446